Evonik strengthens its biosolutions with the establishment of the Botanicals & Natural Actives segment
Evonik announced the establishment of a new segment to strengthen its supply of botanicals and natural active. The division leverages its legacy product portfolio as well as expertise gained through a series of acquisitions to meet the growing market demand for botanicals extracts and natural actives, complementing its recently established Dermatological Research Institute.
The Botanicals & Natural Actives segment was founded after Evonik made several acquisitions in the biotechnology sector: In 2016, Evonik acquired ALKION Biopharma, a cosmetic active ingredients company specializing in biotechnology development; in 2021, it acquired Botanica, a Swiss sustainable botanical medicine pioneer, and Wilshire, a phytochemical supplier. In 2023, the acquisition of Argentinian biotech company Novachem further expanded its product portfolio of natural and sustainable active ingredients for skin and hair care.
As part of the Nutrition & Care division of Evonik Life Sciences, the new Botanicals & Natural Actives segment offers customers highly differentiated biotech natural actives as standard products, using a business-for-business (B4B) approach, and offers tailor-made plant-inspired solutions for its beauty and personal care product portfolio.
"Nature is an infinite source of inspiration for beauty and happiness. We see huge market opportunities waiting to be tapped. I look forward to more cooperation and exchanges with our customers." said Kai-Steffen Krannig, Head of Evonik’s Botanicals & Natural Actives segment.
Evonik's traditional product portfolios of TEGO® curcumone natural plant extracts, TEGO®enlight natural brightening mixture and TEGO® natural betaine skin natural amino acid derivatives have also become the core of the new market segment. Thanks to its recently launched Skin Research Institute, the company will be better able to meet market demand for botanical extracts and natural actives.
The formation of the Botanicals & Natural Actives segment is part of Evonik’s strategic transformation of its Care Solutions business line into a professional partner for the sustainable personal care industry. By leveraging the synergies between these powerful and complementary technology platforms, Evonik is enhancing its entire product portfolio, creating new universal solutions, opening up new markets, accelerating growth and creating significant value.
2026-10-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BASF and Evonik Rumored Potential Acquisition or Merger
-
Evonik Expands Slovakian Fermas Site with €80 Million Investment to Boost Pharmaceutical CDMO Capacity
-
Evonik to Close Two German Plants, Further Cutting Europe’s High-Purity Silicon Tetrachloride Capacity
-
Multiple Chemical Industry Leaders Post Strong H1 Earnings Growth as Sector Profitability Revives
-
Evonik Inaugurates New Speciality Alumina Plant in Japan, Bolstering Regional Growth Strategy
-
Evonik and AMSilk Expand Collaboration to Develop Sustainable Biotech Silk Materials
-
Evonik Launches Asia’s First Alkoxide Plant in Jurong Island
-
Evonik Converts Epoxy Hardener Production to 100% Renewable Electricity
-
Breakup! Vland Biotech and Evonik Part Ways as GHS Joint Venture Falls Short of Expectations
-
Evonik Completes Shift to Green Electricity for Polybutadiene Production at its Marl, Germany, Plant
Recommend Reading
-
CordenPharma Invests €80 Million to Raise Sterile Injectable Capacity to 500 Million Units Annually
-
ZPC Plans 1.2 Million-Tonne PDH Unit, Setting a New Global Licensing Record
-
L Catterton to Acquire Minority Stake in Perfume Company EX NIHILO
-
Trump Places Glyphosate Under the Defense Production Act, Turning Bayer from a Corporation into a “National Asset”
-
Trump Places Glyphosate Under the Defense Production Act, Turning Bayer from a Corporation into a “National Asset”
-
Business Society October 14, 2026 DOP Trend Analysis: Strongly Bullish
-
Business Society October 14, 2026 Lithium Carbonate Trend Analysis: Volatility
-
Business Society October 14, 2026 Toluene Trend Analysis: Volatility
-
Weak demand leads to consolidation in China's anhydrous hydrogen fluoride market
-
Business Society October 13, 2026 Maleic Anhydride Trend Analysis: Rising